TRANSPLANT-RELATED HEMATOLOGIC MALIGNANCY

Clinical trials for TRANSPLANT-RELATED HEMATOLOGIC MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new TRANSPLANT-RELATED HEMATOLOGIC MALIGNANCY trials appear

Sign up with your email to follow new studies for TRANSPLANT-RELATED HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for faster, safer recovery after High-Risk cancer transplants

Disease control Recruiting now

This study is testing if a drug called sargramostim can help patients recover their immune cells faster and with fewer serious infections after a half-matched stem cell transplant for blood cancers. It will involve about 38 patients who have a partially matched family donor. Rese…

Matched conditions: TRANSPLANT-RELATED HEMATOLOGIC MALIGNANCY

Phase: PHASE2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

TRANSPLANT-RELATED HEMATOLOGIC MALIGNANCY

Get alerted when new TRANSPLANT-RELATED HEMATOLOGIC MALIGNANCY trials appear

New hope for faster, safer recovery after High-Risk cancer transplants